Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06061874

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis

Led by Jules Bordet Institute · Updated on 2025-03-31

80

Participants Needed

1

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, phase II, non-randomized clinical imaging trial. Ga68-FAPI-46 is a novel radiotracer used in PET/CT imaging, targeting a protein of the tumor microenvironment called FAP (Fibroblast activation protein). The aim of the study is to assess the accuracy of Ga68-FAPI-46 PET/CT for preoperative assessment of peritoneal carcinomatosis in colorectal and ovarian cancer.

CONDITIONS

Official Title

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically proven colorectal and ovarian cancer.
  • Known or suspected peritoneal metastases from the tumour of origin.
  • Scheduled for peritoneal complete cytoreductive surgery with curative intent with or without neoadjuvant chemotherapy.
  • ECOG Performance status 2.
  • Signed written informed consent obtained before any study-specific screening procedures.
Not Eligible

You will not qualify if you...

  • Non-resectable extra-abdominal metastasis and/or more than 3 hepatic metastases on standard work-up.
  • Known chronic inflammatory conditions including the intestinal system (eg. inflammatory bowel disease, Crohn's disease).
  • Pregnant and lactating women.
  • Previous or concurrent malignancy diagnosed within the last 3 years except adequately treated in situ carcinoma of the cervix uteri and basal or squamous cell skin cancer.
  • Subjects with another significant medical condition which, in the investigator's opinion, may interfere with the completion of the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Jules Bordet

Brussels, Belgium

Actively Recruiting

Loading map...

Research Team

L

Loubna Taraji Schiltz

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis | DecenTrialz